{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-PRIME/4528",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# ONO PHARMACEUTICAL CO.,LTD. (Prime Market: 4528) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is ONO PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4528. The ISIN is not on the record; the LEI is 529900G26L4NG4GFJZ86. The security type is Corporate, the segment is not on the record, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 12 filings in the twelve months to 2026-11-06, across 7 filing days. The filings comprise 3 ad hoc, 6 regulatory filing and 3 results. The median gap between filing days is 60.5 days. The latest filing is dated 2026-11-05, is of type regulatory filing, and falls 1 day before the record date. The Prime Market median is 29.0 days of cadence, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical sector median is 49.5 days of cadence, 8.0 filings and 85.0 days of latency across 80 issuers.\n\n## Auditor\n\nThe auditor of record is 有限責任監査法人 ト ー マ ツ. Its location is not on the record. The auditor changes are not on the record.\n\n## Events and halts\n\nThe listing, delisting, name change, domicile change and segment move lines are not on the record, because the register has no lifecycle type map yet. The issuer is listed and not halted.\n\n## Orderability\n\nFor the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's own investor-relations page names 14 research houses: BofA Securities Japan Co., Ltd., Citigroup Global Markets Japan Inc., CLSA Securities Japan Co., Ltd., Daiwa Securities Co., Ltd., Goldman Sachs Japan Co., Ltd., Jefferies Japan Limited, J.P. Morgan Securities Japan Co., Ltd., Mizuho Securities Co., Ltd., Morgan Stanley MUFG Securities Co., Ltd., Nomura Securities Co., Ltd., Pathology Associates, SBI SECURITIES Co.,Ltd., SMBC Nikko Securities Inc., and UBS AG.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/529900G26L4NG4GFJZ86 (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4528 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YA20 (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.ono-pharma.com/en/ir/stock/analyst (coverage)\n- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4528 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YA20",
    "state": "sourced",
    "value": "有限責任監査法人　ト ー マ ツ"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-PRIME/4528",
  "coverage": {
   "count": 14,
   "houses": [
    {
     "analyst": "Koichi Mamegano",
     "house": "BofA Securities Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Hidemaru Yamaguchi",
     "house": "Citigroup Global Markets Japan Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Zhijie Zhao, David Dong",
     "house": "CLSA Securities Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Kazuaki Hashiguchi",
     "house": "Daiwa Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Akinori Ueda, Tomo Taniguchi",
     "house": "Goldman Sachs Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Stephen Barker, Miyabi Yamakita",
     "house": "Jefferies Japan Limited",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Seiji Wakao",
     "house": "J.P. Morgan Securities Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Yuriko Ishida, Hiroshi Tanaka",
     "house": "Mizuho Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Shinichiro Muraoka, Lee Jaeheon",
     "house": "Morgan Stanley MUFG Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Hiroyuki Matsubara",
     "house": "Nomura Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Dion Stéfan Büchner",
     "house": "Pathology Associates",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Ryuta Kawamura",
     "house": "SBI SECURITIES Co.,Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Hiroshi Wada",
     "house": "SMBC Nikko Securities Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    },
    {
     "analyst": "Atsushi Seki, Mark Yokoyama",
     "house": "UBS AG",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.ono-pharma.com/en/ir/stock/analyst",
     "result": "read: 14 of 28 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1557,
     "median_cadence_gap_days": 29,
     "median_filings": 10,
     "median_latency_days": 70,
     "name": "Prime Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 3,
    "regulatory_filing": 6,
    "results": 3
   },
   "cadence_median_gap_days": 60.5,
   "filing_days": 7,
   "filings": 12,
   "latency_days": 1,
   "latest": [
    {
     "category": "135",
     "date": "2026-11-05",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100ZBG6",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-11-05",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100ZBG1",
     "title": "半期報告書－第79期(2026/04/01－2027/03/31)",
     "type": "results"
    },
    {
     "category": "135",
     "date": "2026-07-08",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YPI8",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "訂正有価証券報告書 (amended annual report)",
     "date": "2026-07-08",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YOIE",
     "title": "訂正有価証券報告書－第78期(2025/04/01－2026/03/31)",
     "type": "regulatory_filing"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-06-19",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YDVI",
     "title": "臨時報告書",
     "type": "ad_hoc"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4528",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Prime Market"
   },
   "isin": {
    "market": "JP",
    "reason": "GLEIF maps no ISIN to this LEI",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF name-exact (English name against the legal or other names, jurisdiction JP; GLEIF golden copy 2026-09-12)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/529900G26L4NG4GFJZ86",
    "state": "sourced",
    "value": "529900G26L4NG4GFJZ86"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "ONO PHARMACEUTICAL CO.,LTD."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4528"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:20b920c362e6805c520d0853e9f10e89764c8191f47cae410faf0c2eb78a51a2",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope and the subject's record carries no instrument class to place within it",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4528",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:20b920c362e6805c520d0853e9f10e89764c8191f47cae410faf0c2eb78a51a2",
 "path": "/jp/TSE-PRIME/4528",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is ONO PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4528. The ISIN is not on the record; the LEI is 529900G26L4NG4GFJZ86. The security type is Corporate, the segment is not on the record, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 12 filings in the twelve months to 2026-11-06, across 7 filing days. The filings comprise 3 ad hoc, 6 regulatory filing and 3 results. The median gap between filing days is 60.5 days. The latest filing is dated 2026-11-05, is of type regulatory filing, and falls 1 day before the record date. The Prime Market median is 29.0 days of cadence, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical sector median is 49.5 days of cadence, 8.0 filings and 85.0 days of latency across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 有限責任監査法人 ト ー マ ツ. Its location is not on the record. The auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The listing, delisting, name change, domicile change and segment move lines are not on the record, because the register has no lifecycle type map yet. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's own investor-relations page names 14 research houses: BofA Securities Japan Co., Ltd., Citigroup Global Markets Japan Inc., CLSA Securities Japan Co., Ltd., Daiwa Securities Co., Ltd., Goldman Sachs Japan Co., Ltd., Jefferies Japan Limited, J.P. Morgan Securities Japan Co., Ltd., Mizuho Securities Co., Ltd., Morgan Stanley MUFG Securities Co., Ltd., Nomura Securities Co., Ltd., Pathology Associates, SBI SECURITIES Co.,Ltd., SMBC Nikko Securities Inc., and UBS AG.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/529900G26L4NG4GFJZ86"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4528"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YA20"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.ono-pharma.com/en/ir/stock/analyst"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4528"
  }
 ],
 "title": "ONO PHARMACEUTICAL CO.,LTD. (4528) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}